Celldex Therapeutics | CLDX - L'Utile Operativo





L'Utile Operativo Cambiamento Data
AbbVie USD 6.72B 1.99B 2026-06
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.61B 777M 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Celldex Therapeutics USD -80.62M 3.81M 2026-06
Glaxosmithkline GBP 2.29B 3.08M 2026-03
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Pfizer USD 667M 4.32B 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 11.46B 1.91B 2026-06